CADM1 and neuroblastoma: CADM1 is known to be involved in inhibition of cell proliferation and induction of apoptosis with a reported loss of expression in a variety of cancers of epithelial cell origin such as breast, prostate, pancreatic, hepatocellular and colorectal cancer, but also in neuroblastoma (reviewed in [16]).